Back to Newsroom

LIBERTY HEALTH SCIENCES APPLAUDS PROTECTIONS PROVIDED BY CONGRESS FOR STATE-APPROVED MEDICAL CANNABIS LAWS

Toronto, Ontario – March 23, 2018 – Liberty Health Sciences Inc. (CSE: LHS or US OTCBB: LHSIF) (the “Company” or “Liberty”) applauds today’s passage of the 2018 omnibus appropriations package, which includes the Rohrabacher-Leahy Amendment (“Rohrabacher-Leahy”) restricting the Department of Justice (“DOJ”) from interfering with the rights of patients and medical cannabis companies such as Liberty operating in compliance with State laws. As a result, the DOJ will not be able to pursue enforcement actions against legal medical cannabis cultivators, distributors and licensees operating in compliance with State laws, thereby protecting Liberty’s business, operations and patients.
READ MORE…